Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud’s phenomenon secondary to systemic sclerosis
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (12) , 1555-1557
- https://doi.org/10.1016/s0002-9149(98)00708-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud’s phenomenonAmerican Heart Journal, 1998
- Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In VivoCirculation, 1995
- Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal WomenAnnals of Internal Medicine, 1994
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Crucial role of endothelium in the vasodilator response to increased flow in vivo.Hypertension, 1986
- Morphologic Changes in the Digital Arteries of Patients with Progressive Systemic Sclerosis (Scleroderma) and Raynaud PhenomenonMedicine, 1980
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Morphometry of intrarenal arteries in progressive sclerosisVirchows Archiv, 1980